← Back

CVE-2021-43935

nvd nist
Published: Dec 15, 2021Modified: Nov 21, 2024

JSON object

Loading...
9.8
Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Exploitability: 3.9 / Impact: 5.9
Source: NVD

Description

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.

Affected (7)

Configuration A
4 vulnerable
Configuration B
1 vulnerable · 1 platform
Vulnerable SoftwareAffected Versions
From 5.01 to 6.4.0
Running on/withPlatform Versions
Baxter
Welch Allyn Hscribe Holter Analysis System
All versions
Configuration C
1 vulnerable · 1 platform
Vulnerable SoftwareAffected Versions
From 6.0.0 to 6.3.1
Running on/withPlatform Versions
Baxter
Welch Allyn Q Stress Cardiac Stress Testing System
All versions
Configuration D
1 vulnerable · 1 platform
Vulnerable SoftwareAffected Versions
From 5.01 to 6.3.1
Running on/withPlatform Versions
Baxter
Welch Allyn Xscribe Cardiac Stress Testing System
All versions

References (2)

Source: ics-cert@hq.dhs.gov
MitigationThird Party AdvisoryUS Government Resource
Source: af854a3a-2127-422b-91ae-364da2661108
MitigationThird Party AdvisoryUS Government Resource

Timeline

No history available yet.